Trade Eli Lilly ^LLY

U.S. Market Brief: Indices Advance as Investors Hope for Iran War Resolution

Stock market today: Dow, S&P 500, Nasdaq extend rally for 2nd day on hopes of Iran war deescalation

FDA approves Lilly's Foundayo, first unrestricted GLP-1 pill

Eli Lilly stock pops after FDA approves new GLP-1 weight-loss pill

FDA approves Eli Lilly's Foundayo pill for weight loss

Eli Lilly weight loss pill Foundayo approved by FDA, shares rise

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions | Morningstar

Traders Buy High Volume of Eli Lilly and Company Call Options (NYSE:LLY) - Daily Political

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

Gemcitabine Hydrochloride Market Report 2026-2030 & 2035 Featuring Strategic Analysis of Fresenius Kabi, Eli Lilly and Company, Teva Pharma, Intas Pharma, Mylan and More

Eli Lilly and Company $LLY Shares Sold by Goelzer Investment Management Inc.

Centessa (CNTA) Soars to All-Time High on 38% Upside from Eli Lilly Merger

Goelzer Investment Management Inc. Cuts Stock Position in Eli Lilly and Company $LLY - Daily Political

Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly

Pharmaceutical Stocks To Watch Today - March 31st

Centessa Pharmaceuticals Stock Soars 45% Over Acquisition Deal With Eli Lilly And Company

Eli Lilly Is Bringing AI-Developed Drugs to Market. Should You Buy LLY Stock to Profit?

Chesley Taft & Associates LLC Buys 1,518 Shares of Eli Lilly and Company $LLY

Eli Lilly and Company $LLY Shares Acquired by Worth Asset Management LLC - Stock Observer

Vanda's tradipitant has phase II success but a court setback | BioWorld

Lilly shifts from obesity to narcolepsy with $7.8B Centessa buy | BioWorld

A deep joint-learning proteomics model for diagnosis of six conditions associated with dementia

Eli Lilly and Company (NYSE:LLY) Price Target Lowered to $1,163.00 at Guggenheim

Eli Lilly and Company (LLY) Continued to Gain from Its Incretin Portfolio

Eli Lilly's (LLY) Shares Up Since Jim Cramer Said He Was a Long Term Believer

Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes

Eli Lilly and Company $LLY Stake Boosted by Matrix Trust Co

Mather Group LLC. Purchases 2,250 Shares of Eli Lilly and Company $LLY

Trending tickers: Exxon Mobil, Eli Lilly, Rio Tinto and Boohoo

Eli Lilly and Company $LLY Shares Acquired by Exchange Traded Concepts LLC

Dakota Wealth Management Reduces Holdings in Eli Lilly and Company $LLY

Guggenheim Lowers Eli Lilly and Company (NYSE:LLY) Price Target to $1,163.00 - Daily Political

Lilly taps Insilico AI in $2.75B deal to expand pipeline options | BioWorld

Eli Lilly seeks higher NHS drug prices, rebate overhaul to restart UK investment, FT reports - Yahoo News Canada

Insilico Medicine partners with Lilly on drug discovery collaboration

Insilico Medicine Announces Global R&D Collaboration with Lilly

Jefferies Remains a Buy on Eli Lilly and Company (LLY)

Best Medical Stocks To Follow Today - March 29th - Markets Daily

Insilico Medicine Strikes $2.75 Bln AI Drug Discovery Deal With Eli Lilly

Hong Kong-listed AI drug discovery company Insilico Medicine and Eli Lilly sign a drug co-development deal worth up to $2.75B, with $115M in upfront payments (Evelyn Cheng/CNBC)

Eli Lilly and Company $LLY Shares Acquired by World Investment Advisors

Top Pharmaceutical Stocks To Follow Now - March 29th - Daily Political

Signal Advisors Wealth LLC Buys 824 Shares of Eli Lilly and Company $LLY - Markets Daily

Synergy Asset Management LLC Sells 50,043 Shares of Eli Lilly and Company $LLY

Syquant Capital Sas Purchases Shares of 71,000 Eli Lilly and Company $LLY

Cadent Capital Advisors LLC Acquires 1,231 Shares of Eli Lilly and Company $LLY

Syquant Capital Sas Takes Position in Eli Lilly and Company $LLY - Stock Observer

Eli Lilly and Company (NYSE:LLY) Rating Increased to Strong-Buy at Wall Street Zen

Phase 3b data presented at AAD Annual Meeting show Lilly's Taltz (ixekizumab) plus Zepbound (tirzepatide) delivered superior efficacy for adults with psoriatic arthritis and obesity

Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program

Top Pharmaceutical Stocks To Watch Today - March 25th - Markets Daily

PPH ETF: Drug Pricing Policy and Eli Lilly Concentration Are the Two Risks to Watch in 2026

Medical Stocks Worth Watching - March 28th - Daily Political

Czech National Bank Boosts Holdings in Eli Lilly and Company $LLY

Promising Pharmaceutical Stocks To Keep An Eye On - March 27th - Markets Daily

Janus Henderson Forty Fund's Updates on Eli Lilly and Company (LLY)

Eli Lilly and Company (NYSE:LLY) Shares Down 2.1% - Should You Sell? - Daily Political

20261000: Eli Lilly and Company; InSilico Medicine Cayman TopCo

Eli Lilly and Company (NYSE:LLY) Stock Price Up 1.4% - Here's Why - Daily Political

Medical Stocks To Research - March 27th - Stock Observer

FY2027 Earnings Forecast for LLY Issued By Erste Group Bank - Markets Daily

Lilly's EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis | Morningstar

Pensionfund Sabic Takes $1.83 Million Position in Eli Lilly and Company $LLY - Markets Daily

Eli Lilly and Company $LLY Shares Bought by DAVENPORT & Co LLC

Eli Lilly and Company $LLY Shares Sold by Founders Grove Wealth Partners LLC

Bath Savings Trust Co Increases Stake in Eli Lilly and Company $LLY

Pensionfund Sabic Makes New Investment in Eli Lilly and Company $LLY - Stock Observer

Eli Lilly and Company (NYSE:LLY) Receives Average Recommendation of "Moderate Buy" from Brokerages

Viking Fund Management LLC Trims Stock Position in Eli Lilly and Company $LLY - Daily Political

Moody National Bank Trust Division Has $7.48 Million Position in Eli Lilly and Company $LLY - Daily Political

Research Analysts' Weekly Ratings Updates for Eli Lilly and Company (LLY) - Daily Political

Eli Lilly and Company $LLY Shares Acquired by Meadowbrook Wealth Management LLC - Daily Political

FDA Approval Of Awiqli Adds New Dimension To Novo Nordisk Story

Eli Lilly and Company (NYSE:LLY) Trading Down 1.9% - Here's What Happened

Eli Lilly and Company (NYSE:LLY) Shares Down 1.9% - What's Next? - Markets Daily

Metastatic Triple-Negative Breast Cancer Market: Strong Growth Potential Across APAC Through 2036, Driven by Innovation and Rising Disease Burden | DelveInsight

Stock market today: Dow, S&P 500, Nasdaq sink as Wall Street weighs prospects for Iran truce

Stock market today: Dow, S&P 500, Nasdaq fall as Wall Street weighs prospects for Iran truce

Scott Capital Advisors LLC Has $290,000 Position in Eli Lilly and Company $LLY - Markets Daily

Best Pharmaceutical Stocks To Watch Today - March 26th - Daily Political

MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financial and Operational Results | Taiwan News | Mar. 26, 2026 20:00

Branded Pharmaceuticals Stocks Q4 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)

Eli Lilly and Company $LLY Stock Position Cut by BDF Gestion

Avanza Fonder AB Has $33.82 Million Position in Eli Lilly and Company $LLY

Eli Lilly and Company $LLY Shares Sold by Salem Investment Counselors Inc. - Stock Observer

Sen. Angus S. King Jr. Sells Off Shares of Eli Lilly and Company (NYSE:LLY)

Overbrook Management Corp Has $30.40 Million Stock Position in Eli Lilly and Company $LLY - Daily Political

Eli Lilly and Company (NYSE:LLY) Stock Price Up 1.4% - Should You Buy?